Fresenius Medical Care AG (FMS)
NYSE: FMS · Real-Time Price · USD
23.25
-0.12 (-0.51%)
Dec 5, 2025, 4:00 PM EST - Market closed
Fresenius Medical Care AG Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Fresenius Medical Care AG stock has a target of 30, which predicts a 29.03% increase from the current stock price of 23.25.
Price Target: $30.00 (+29.03%)
Analyst Consensus: Sell
* Price targets were last updated on May 12, 2025.
Analyst Ratings
The average analyst rating for Fresenius Medical Care AG stock is "Sell". This means that analysts believe this stock is likely to lead to lower returns than market as a whole.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 1 | 1 | 1 | 1 |
| Total | 1 | 1 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Hold → Strong Sell Downgrades n/a | Hold → Strong Sell | Downgrades | n/a | n/a | Sep 2, 2025 |
| Truist Securities | Truist Securities | Hold Maintains $25 → $30 | Hold | Maintains | $25 → $30 | +29.03% | May 12, 2025 |
| Truist Securities | Truist Securities | Hold Maintains $23 → $25 | Hold | Maintains | $23 → $25 | +7.53% | Jan 6, 2025 |
| Truist Securities | Truist Securities | Hold Maintains $22 → $23 | Hold | Maintains | $22 → $23 | -1.08% | Oct 7, 2024 |
| Truist Securities | Truist Securities | Hold Maintains $24 → $22 | Hold | Maintains | $24 → $22 | -5.38% | Jul 31, 2024 |
Financial Forecast
Revenue This Year
19.75B
from 19.34B
Increased by 2.12%
Revenue Next Year
20.32B
from 19.75B
Increased by 2.92%
EPS This Year
3.95
from 1.83
Increased by 115.81%
EPS Next Year
4.14
from 3.95
Increased by 4.85%
Financial currency is EUR. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 20.7B | 21.6B | ||||
| Avg | 19.7B | 20.3B | ||||
| Low | 18.8B | 19.4B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 7.0% | 9.4% | ||||
| Avg | 2.1% | 2.9% | ||||
| Low | -2.7% | -1.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 4.41 | 4.85 | ||||
| Avg | 3.95 | 4.14 | ||||
| Low | 3.43 | 2.35 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 141.0% | 22.8% | ||||
| Avg | 115.8% | 4.8% | ||||
| Low | 87.4% | -40.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.